换一批
换一批Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials.
第一作者：
Kleoniki,Apostolidou
第一单位：
Department of Clinical Therapeutics, Alexandra Hospital, Medical School, Athens, 11528, Greece. Electronic address: apostolidoukl@gmail.com.
作者：
主题词
人类(Humans);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);细胞周期蛋白依赖激酶4(Cyclin-Dependent Kinase 4);细胞周期蛋白依赖激酶6(Cyclin-Dependent Kinase 6);蛋白激酶抑制剂(Protein Kinase Inhibitors);选择性雌激素受体调节剂(Selective Estrogen Receptor Modulators);投药, 口服(Administration, Oral);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);临床试验(主题)(Clinical Trials as Topic)
DOI
10.1016/j.breast.2024.103729
PMID
38599049
发布时间
2024-12-08
- 浏览0
Breast (Edinburgh, Scotland)
103729页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
